Found 7 matching trials
Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859 PHASE1 The purpose of this study is to determine the safety, tolerability and phar...
Show More Location
Pfizer New Haven Clinical Research Unit
Learn More & Join Trial
A Study In Adults With Moderate To Severe Dermatomyositis PHASE2 A Study looking at Investigational drug and Placebo administered to adult P...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. PHASE2 The purpose of this study is to learn about the effects, safety and how PF-...
Show More Location
The Kirklin Clinic of UAB Hospital
Learn More & Join Trial
A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants PHASE1 The purpose of this clinical trial is to learn if the study medicine (calle...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] PHASE3 The purpose of the study is to understand how the study medicine PF-0682385...
Show More Location
Arizona Arthritis & Rheumatology Research, PLLC
Learn More & Join Trial
Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants PHASE1 Purpose of the study is to evaluate the safety, tolerability, immunogenicit...
Show More Location
Medical Corporation Shinanokai Shinanozaka Clinic
Learn More & Join Trial
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study PHASE2 The purpose of this research study is to evaluate the long-term safety, and...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial